Omega-3 Fatty Acid Based Nanolipid Formulation of Atorvastatin for Treating Hyperlipidemia

Revathy Sreedhar ¹ , Vrinda Sasi Kumar ¹ , Anil Kumar Bhaskaran Pillai ² , Sabitha Mangalathillam ¹ *

Cited by CrossRef: 12

1- Shehata T, Khalil H, Elsewedy H, Soliman W. Myrrh essential oil-based nanolipid formulation for enhancement of the antihyperlipidemic effect of atorvastatin. Journal of Drug Delivery Science and Technology. 2021;61:102277 [Crossref]

2- Singh S, Zahoor I, Sharma N, Behl T, Kanojia N, Sehgal A, Mohan S, Almoshari Y, Salawi A, Aleya L, Bungau S. Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia. Environ Sci Pollut Res. 2022;29(51):76514 [Crossref]

3- R. Gardouh A, M. Nasef A, Mostafa Y, Gad S. Impact on HDL and LDL of Hyperlipidemic Rat Models: Designed Solid Self-Nanoemulsifying Drug Delivery Systems with Atorvastatin and Ezetimibe combination. RJPT. 2022;:2459 [Crossref]

4- Kaewmalun S, Yata T, Kitiyodom S, Yostawonkul J, Namdee K, Kamble M, Pirarat N. Clove Oil-Nanostructured Lipid Carriers: A Platform of Herbal Anesthetics in Whiteleg Shrimp (Penaeus vannamei). Foods. 2022;11(20):3162 [Crossref]

5- Nistor M, Rugina D, Diaconeasa Z, Socaciu C, Socaciu M. Pentacyclic Triterpenoid Phytochemicals with Anticancer Activity: Updated Studies on Mechanisms and Targeted Delivery. IJMS. 2023;24(16):12923 [Crossref]

6- Domingues I, Leclercq I, Beloqui A. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery. Journal of Controlled Release. 2023;363:415 [Crossref]

7- Victor F, Rehman K, Akash M, Rasheed S, Imran M, Assiri M. Technological Advancement in ω-3 Fatty Acids: Their Therapeutic Functions and Novel Delivery Strategies. CPD. 2023;29(12):893 [Crossref]

8- Kumar V, KP V, M S. Anticonvulsant and acute toxicity evaluation of phenytoin sodium–loaded polymeric nanomicelle in MES rat model. J Nanopart Res. 2022;24(8) [Crossref]

9- Amer R, Yassin G, Mohamed R, Fayez A. Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats. AAPS PharmSciTech. 2021;22(5) [Crossref]

10- Manners N, Priya V, Mehata A, Rawat M, Mohan S, Makeen H, Albratty M, Albarrati A, Meraya A, Muthu M. Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives. Pharmaceuticals. 2022;15(4):441 [Crossref]

11- Ahmed O, Fahmy U, Bakhaidar R, El-Moselhy M, Okbazghi S, Ahmed A, Hammad A, Alhakamy N. RETRACTED: Omega-3 Self-Nanoemulsion Role in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats. Pharmaceutics. 2020;12(2):140 [Crossref]

12- Ahmad M, Ahmad J, Zafar S, Warsi M, Abdel-Wahab B, Akhter S, Alam M. Omega-3 fatty acids as adjunctive therapeutics: prospective of nanoparticles in its formulation development. Therapeutic Delivery. 2020;11(1):851 [Crossref]